Wells Fargo Resumes Coverage on Pharmaceutical Product Development (PPDI) at Outperform; Sustainable Margin Advantage
Tweet Send to a Friend
Wells Fargo resumes coverage on Pharmaceutical Product Development (NASDAQ: PPDI) with a Outperform. PT range $31-$33.
Wells analyst says, "PPDI ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells analyst says, "PPDI ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
